首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 23-dideoxynucleosides in vitro.
【2h】

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 23-dideoxynucleosides in vitro.

机译:长期抑制人类T型淋巴病毒III型/淋巴结病相关病毒(人类免疫缺陷病毒)在体外受23-二脱氧核苷保护的T细胞中的DNA合成和RNA表达。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report that 2',3'-dideoxyadenosine and 2',3'-dideoxycytidine inhibit retroviral DNA synthesis and mRNA expression in T cells exposed to the virus that causes acquired immunodeficiency syndrome, and afford such cells long-term protection in vitro under conditions of substantial viral excess. Both 2',3'-dideoxyadenosine and 2',3'-dideoxycytidine appear to completely block reverse transcription from viral RNA to viral DNA. Viral mRNA expression is also not detected in cells protected by the drugs throughout 30 days of culture following exposure to the virus. Purine and pyrimidine analogues as 2',3'-dideoxynucleoside-5'-triphosphate serve as substrates for the human T-lymphotropic virus type III/lymphadenopathy-associated virus reverse transcriptase to elongate a DNA chain by one residue, after which the chain is terminated. Cloned normal helper/inducer T cells exposed to a cytopathic dose of the virus, but protected by the drugs, respond normally to specific antigen in vitro. These results suggest that the drugs could be promising agents for further studies in the experimental treatment of patients infected with retroviruses.
机译:我们报告2',3'-dideoxyadenosine和2',3'-dideoxycytidine抑制暴露于引起获得性免疫缺陷综合症的病毒的T细胞中逆转录病毒DNA合成和mRNA表达,并在条件下在体外提供此类细胞的长期保护大量病毒过量。 2′,3′-二脱氧腺苷和2′,3′-二脱氧胞苷似乎都完全阻断了从病毒RNA到病毒DNA的逆转录。在暴露于病毒后的整个30天培养过程中,在受药物保护的细胞中也未检测到病毒mRNA表达。嘌呤和嘧啶类似物为2',3'-dideoxynucleoside-5'-triphosphate,可作为人类T型淋巴病毒III型/淋巴结病相关病毒逆转录酶的底物,将DNA链延长一个残基,然后将其终止。暴露于细胞病变剂量但受药物保护的克隆的正常辅助/诱导T细胞在体外对特定抗原具有正常反应。这些结果表明,该药物可能是有希望的试剂,可以进一步用于实验治疗感染逆转录病毒的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号